Can vitamin B12 deficiency mask iron deficiency on an MCV test?

Combined iron and vitamin B12 deficiency is a recognized setting in which the mean corpuscular volume (MCV) can be misleading. Rather than showing the expected isolated microcytosis of iron deficiency or macrocytosis of B12 deficiency, opposing effects on red-cell size may yield an apparently unremarkable average.

Clinical evidence

• The claim is strongly supported. In a cohort of 149 patients with concurrent iron and B12 deficiency, 72.5% had a normal MCV and 6.7% had an elevated MCV. Thus, a normal—and occasionally high—MCV does not rule out iron deficiency when B12 deficiency is also present.
• The converse is also important: iron deficiency can blunt the macrocytosis ordinarily associated with B12 deficiency. Classifying anemia from MCV alone can therefore miss a mixed nutritional deficiency.

Mechanistic and hematologic findings

• MCV is an average across circulating red cells, not a measure of whether all cells are similarly sized. Concurrent deficiency can create a dimorphic population: small, hypochromic iron-deficient cells alongside larger, often oval B12-deficient cells.
• This mixture may normalize the average MCV despite substantial abnormalities in both populations. The size heterogeneity is expected to produce an increased red-cell distribution width (RDW), and a peripheral smear may directly show the mixed microcytic–macrocytic pattern.

Practical implications

• Interpretation should integrate MCV with RDW, peripheral smear, iron studies, and B12 testing, rather than treating cell size as a stand-alone exclusion test.
• If B12 findings are indeterminate but clinical suspicion remains, methylmalonic acid testing may help. Ferritin should also be interpreted in context, since inflammation can yield normal or elevated ferritin despite iron deficiency.

Bottom line

• Normal or elevated MCV can mask concurrent iron and vitamin B12 deficiency; mixed red-cell populations and elevated RDW provide important clues beyond the average MCV.